Apitope

Developer of therapeutic peptides for the treatment of autoimmune and allergic diseases

placeDiepenbeek, Flanders, Belgium calendar_todayFounded 2002 groups6 employees language apitope.com

Registered entities

Investor mix

9 investors on record; lead investors include Vesalius Biocapital Partners, LRM.

Investor typeCountShare
Venture capital333%
Private equity111%
Accelerator & incubator111%
Bank & private debt222%
Other / undisclosed222%
Coming soon